Evidence map›Paper›PMID 39962144›Full record

ArticleScientific reports2025

Seroprevalence of Hepatitis A virus infections among schoolchildren in Amran Governorate, Yemen.

Ali Ahmed Al-Hadheq, Majeed Hazzaa Nomaan, Wadhah Hassan Edrees

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali Ahmed Al-HadheqMedical Laboratory Department, Faculty of Medical and Health Sciences, Amran University, Amran, Yemen. alhatheqali@gmail.com.
Majeed Hazzaa NomaanDepartment of Biology, Faculty of Applied Science and Humanities, Amran University, Amran, Yemen.
Wadhah Hassan EdreesMedical Microbiology Department, Faculty of Applied Sciences, Hajjah University, Hajjah, Yemen.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis A virus (HAV) is the predominant cause of acute viral hepatitis worldwide; however, data on HAV prevalence among schoolchildren are limited. This study aimed to investigate HAV seroprevalence among schoolchildren in Amran governorate. This is a cross-sectional study that was carried out among 299 students between October 2023 and July 2024. The blood specimens were collected, and the anti-HAV antibody was detected by an enzyme-linked immunosorbent assay (ELISA) technique. Of 299 students screened, the seropositivity rate for HAV was 4 (1.3%). A higher rate of HAV was detected among male students 3 (1.6%), in the age group of 5-8 years 1 (11.1%), and in those whose parents had a secondary certificate 2 (2.3%). Moreover, a higher seroprevalence of HAV was observed among students who drank untreated water (1.6%) and those with a history of hepatitis A infection (6.7%). Additionally, this result revealed that children whose families had a history of HAV infection had the highest risk factors for HAV infection (OR = 8.9667), and those whose family members had an HAV infection (OR = 1.9029). To combat the HAV requires the implementation of preventive measures aimed at improving hygiene and sanitation, advocating widespread vaccination, and a rapid response to outbreaks of the virus.

Indexed as

Hepatitis AHepatitis A virusAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHepatitis A AntibodiesHumansMaleRisk FactorsSeroepidemiologic StudiesStudentsYemenHepatitis A AntibodiesAmranELISAHAV infectionsPrevalenceSchoolchildrenYemen

Identifiers

PMID39962144
PMCPMC11832734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.